Answers are grounded in this paper and cite their sources.
S-1 is an effective adjuvant treatment for East Asian patients who have undergone a D2 dissection for locally advanced gastric cancer. (ClinicalTrials.gov number, NCT00152217 [ClinicalTrials.gov].).
No takes yet. Share an insight, caveat, or question.
Sakuramoto et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: